Related Experiment Video

Updated: Aug 14, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Direct thrombin inhibitors for the treatment of acute coronary syndromes and during percutaneous coronary

G Paoli1, P A Merlini, D Ardissino

  • 1Ospedale Maggiore, Via Gramsci 14, Parma, Italy. giorgiapaoli@libero.it

Current Pharmaceutical Design
|November 25, 2005
PubMed

Insights

Direct thrombin inhibitors offer superior anticoagulation for acute coronary syndromes compared to heparin. These agents effectively target both circulating and clot-bound thrombin, improving ischemic event prevention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Thrombosis Research

Background:

  • Acute coronary syndromes (ACS) involve plaque rupture and thrombus formation, necessitating anticoagulant therapy.
  • Heparin is widely used but has limitations, including poor inhibition of bound thrombin and variable patient response.
  • Direct thrombin inhibitors (DTIs) offer a biological advantage by targeting both circulating and clot-bound thrombin without significant plasma protein interaction.

Purpose of the Study:

  • To review clinical trials of active-site DTIs in ACS and coronary interventions.
  • To compare the efficacy and safety of DTIs against unfractionated heparin.
  • To discuss ongoing trials and future developments, including combination therapy and oral DTIs.

Main Methods:

  • Overview of principal clinical trials involving active-site direct thrombin inhibitors.
  • Comparative analysis of efficacy and safety data versus unfractionated heparin.
  • Review of ongoing research and potential future clinical applications.

Main Results:

  • DTIs demonstrate biological superiority over heparin in inhibiting thrombin.
  • Clinical trials have evaluated the role of DTIs in ACS and coronary interventions.
  • Comparative data suggests potential benefits in efficacy and safety profiles.

Conclusions:

  • Direct thrombin inhibitors represent a significant advancement in anticoagulant therapy for ACS.
  • Further research is exploring combination therapies and novel oral agents for improved patient outcomes.
  • DTIs offer a more targeted approach to anticoagulation compared to traditional heparin therapy.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...